1、 刘丹丹,常虹,谈敏,等.男性2型糖尿病患者25羟维生素D3及骨代谢指标的变化分析[J]. 安徽医药, 2015,19(2):288-291. 刘丹丹,常虹,谈敏,等.男性2型糖尿病患者25羟维生素D3及骨代谢指标的变化分析[J]. 安徽医药, 2015,19(2):288-291.
2、 RIZZOLI R, BOONEN S, BRANDI M L, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis(ESCEO)[J]. Curr Med Res Opin, 2013, 29(4): 1-9. RIZZOLI R, BOONEN S, BRANDI M L, et al. Vitamin D supplementation in elderly or postmenopausal women: a 2013 update of the 2008 recommendations from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis(ESCEO)[J]. Curr Med Res Opin, 2013, 29(4): 1-9.
3、 LIPS P, van SCHOOR N M. The effect of vitamin D on bone and osteoporosis[J]. Best Pract Res Clin Endocrinol Metab, 2011, 25(4): 585-591. LIPS P, van SCHOOR N M. The effect of vitamin D on bone and osteoporosis[J]. Best Pract Res Clin Endocrinol Metab, 2011, 25(4): 585-591.
4、 邱明才,马中书.应该高度关注维生素D在人体中的广泛生物学作用[J]. 中华内分泌代谢杂志,2013,29(10):825-826. 邱明才,马中书.应该高度关注维生素D在人体中的广泛生物学作用[J]. 中华内分泌代谢杂志,2013,29(10):825-826.
5、 张丽丽,刘敏燕,成晓玲,等.维生素D与骨代谢生化标志物的相关性研究[J]. 标记免疫分析与临床, 2015,22(10):949-955. 张丽丽,刘敏燕,成晓玲,等.维生素D与骨代谢生化标志物的相关性研究[J]. 标记免疫分析与临床, 2015,22(10):949-955.
6、 KANAZAWA L, YAMAGUCHI T, YAMAMOTO M. Relationship between treatments with insulin oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus[J]. J Bone and Miner Metab, 2010,28(12):554-560. KANAZAWA L, YAMAGUCHI T, YAMAMOTO M. Relationship between treatments with insulin oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus[J]. J Bone and Miner Metab, 2010,28(12):554-560.
7、 蒋娥,王自正,孟庆乐,等.老年男性2型糖尿病患者骨密度变化与血糖的相关性[J]. 中国骨质疏松杂志,2013,19(9):961-963. 蒋娥,王自正,孟庆乐,等.老年男性2型糖尿病患者骨密度变化与血糖的相关性[J]. 中国骨质疏松杂志,2013,19(9):961-963.
8、 RATHMANN W, KOSTEV K.Fracture risk in patients with newly diagnosed type 2 diabetes; a retrospective database analysis in primary care[J]. J Diabetes Complications, 2015, 29(6): 766-770. RATHMANN W, KOSTEV K.Fracture risk in patients with newly diagnosed type 2 diabetes; a retrospective database analysis in primary care[J]. J Diabetes Complications, 2015, 29(6): 766-770.
9、 裴育,巴建明.1型和2型糖尿病与骨质疏松症的关系[J]. 中华糖尿病杂志,2016,8(1):12-14. 裴育,巴建明.1型和2型糖尿病与骨质疏松症的关系[J]. 中华糖尿病杂志,2016,8(1):12-14.
10、 JACKULIAK P, PAYER J. Osteoporosis, fractures, and diabetes[J]. Int J Endocrinol, 2014, 2014(3):820615. JACKULIAK P, PAYER J. Osteoporosis, fractures, and diabetes[J]. Int J Endocrinol, 2014, 2014(3):820615.
11、 ANAFOROGLU I, NAR-DEMIRER A, BASCIL-TUTUNCU N, et al.Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes[J]. J Diabetes Complications, 2009, 23(1):12-17. ANAFOROGLU I, NAR-DEMIRER A, BASCIL-TUTUNCU N, et al.Prevalence of osteoporosis and factors affecting bone mineral density among postmenopausal Turkish women with type 2 diabetes[J]. J Diabetes Complications, 2009, 23(1):12-17.
12、 WORLD HEALTH ORGANIZATION. Prevention and management of steoprorsis[J]. World Health Organ Tech Rep Ser, 2003(921):1-164. WORLD HEALTH ORGANIZATION. Prevention and management of steoprorsis[J]. World Health Organ Tech Rep Ser, 2003(921):1-164.
13、 CHINESE DIABETES SOCIETY. Guidelines for prevention and treatment of type 2 diabetes in China (2013 Edition)[J]. Chin J Diabetes Mellitus, 2014, 6(7):447-498. CHINESE DIABETES SOCIETY. Guidelines for prevention and treatment of type 2 diabetes in China (2013 Edition)[J]. Chin J Diabetes Mellitus, 2014, 6(7):447-498.
14、 田勇.2型糖尿病并发骨质疏松临床分析[J]. 当代医学,2014, 20(l):70-71. 田勇.2型糖尿病并发骨质疏松临床分析[J]. 当代医学,2014, 20(l):70-71.
